Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme
- DOI
- 10.1016/s2214-109x(20)30396-x
- Published
- 2021-01
- Container
- The Lancet Global Health
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s2214-109x-20-30396-x,
title = {Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme},
author = {Jan Hendrik Richardus and Anuj Tiwari and Tanja Barth-Jaeggi and Mohammad A Arif and Nand Lal Banstola and Rabindra Baskota and David Blaney and David J Blok and Marc Bonenberger and Teky Budiawan and Arielle Cavaliero and Zaahira Gani and Helena Greter and Eliane Ignotti and Deusdedit V Kamara and Christa Kasang and Pratap R Manglani and Liesbeth Mieras and Blasdus F Njako and Tiara Pakasi and Basu Dev Pandey and Paul Saunderson and Rajbir Singh and W Cairns S Smith and René Stäheli and Nayani D Suriyarachchi and Aye Tin Maung and Tin Shwe and Jan van Berkel and Wim H van Brakel and Bart Vander Plaetse and Marcos Virmond and Millawage S D Wijesinghe and Ann Aerts and Peter Steinmann},
year = {2021},
journal = {The Lancet Global Health},
doi = {10.1016/s2214-109x(20)30396-x},
url = {https://doi.org/10.1016/s2214-109x(20)30396-x}
}RIS
TY - JOUR TI - Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme AU - Jan Hendrik Richardus AU - Anuj Tiwari AU - Tanja Barth-Jaeggi AU - Mohammad A Arif AU - Nand Lal Banstola AU - Rabindra Baskota AU - David Blaney AU - David J Blok AU - Marc Bonenberger AU - Teky Budiawan AU - Arielle Cavaliero AU - Zaahira Gani AU - Helena Greter AU - Eliane Ignotti AU - Deusdedit V Kamara AU - Christa Kasang AU - Pratap R Manglani AU - Liesbeth Mieras AU - Blasdus F Njako AU - Tiara Pakasi AU - Basu Dev Pandey AU - Paul Saunderson AU - Rajbir Singh AU - W Cairns S Smith AU - René Stäheli AU - Nayani D Suriyarachchi AU - Aye Tin Maung AU - Tin Shwe AU - Jan van Berkel AU - Wim H van Brakel AU - Bart Vander Plaetse AU - Marcos Virmond AU - Millawage S D Wijesinghe AU - Ann Aerts AU - Peter Steinmann PY - 2021 JO - The Lancet Global Health DO - 10.1016/s2214-109x(20)30396-x UR - https://doi.org/10.1016/s2214-109x(20)30396-x ER -
APA
Richardus, J. H., Tiwari, A., Barth-Jaeggi, T., Arif, M. A., Banstola, N. L., Baskota, R., Blaney, D., Blok, D. J., Bonenberger, M., Budiawan, T., Cavaliero, A., Gani, Z., Greter, H., Ignotti, E., Kamara, D. V., Kasang, C., Manglani, P. R., Mieras, L., Njako, B. F., Pakasi, T., Pandey, B. D., Saunderson, P., Singh, R., Smith, W. C. S., Stäheli, R., Suriyarachchi, N. D., Maung, A. T., Shwe, T., Berkel, J. V., Brakel, W. H. V., Plaetse, B. V., Virmond, M., Wijesinghe, M. S. D., Aerts, A., & Steinmann, P. (2021). Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(20)30396-x
Source records
- crossref · retrieved 2026-09-26T06:38:35.893Z